Oracle Corporation (ORCL)vsZepp Health Corp (ZEPP)
ORCL
Oracle Corporation
$114.99
-4.21%
TECHNOLOGY · Cap: $365.96B
ZEPP
Zepp Health Corp
$4.90
-2.20%
TECHNOLOGY · Cap: $79.19M
Smart Verdict
WallStSmart Research — data-driven comparison
Oracle Corporation generates 24672% more annual revenue ($67.36B vs $271.91M). ORCL leads profitability with a 25.4% profit margin vs -14.7%. ORCL earns a higher WallStSmart Score of 76/100 (B+).
ORCL
Strong Buy76
out of 100
Grade: B+
ZEPP
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-14.3%
Fair Value
$105.04
Current Price
$114.99
$9.95 premium
Intrinsic value data unavailable for ZEPP.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 40 in profit
Strong operational efficiency at 36.2%
Keeps 25 of every $100 in revenue as profit
Growing faster than its price suggests
Revenue surging 20.6% year-over-year
Reasonable price relative to book value
Revenue surging 33.8% year-over-year
Areas to Watch
Trading at 8.8x book value
Weak financial health signals
Negative free cash flow — burning cash
Distress zone — elevated risk
Smaller company, higher risk/reward
Elevated debt levels
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Comparative Analysis Report
WallStSmart ResearchBull Case : ORCL
The strongest argument for ORCL centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 25.4% and operating margin at 36.2%. Revenue growth of 20.6% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 33.8% demonstrates continued momentum.
Bear Case : ORCL
The primary concerns for ORCL are Price/Book, Piotroski F-Score, Free Cash Flow. Debt-to-equity of 3.67 is elevated, increasing financial risk.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Debt/Equity, Return on Equity.
Key Dynamics to Monitor
ORCL profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.84 — expect wider price swings.
ZEPP is growing revenue faster at 33.8% — sustainability is the question.
ZEPP generates stronger free cash flow (-26M), providing more financial flexibility.
Bottom Line
ORCL scores higher overall (76/100 vs 42/100), backed by strong 25.4% margins and 20.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Oracle Corporation
TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA
Oracle is an American multinational computer technology corporation headquartered in Austin, Texas. The company was formerly headquartered in Redwood Shores, California until December 2020 when it moved its headquarters to Texas. The company sells database software and technology, cloud engineered systems, and enterprise software products, particularly its own brands of database management systems.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - INFRASTRUCTURE Stocks
Want to dig deeper into these stocks?